Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer

Marike Gabrielson, Kumari Ubhayasekera, Bo Ek, Mikael Andersson Franko,Mikael Eriksson, Kamila Czene, Jonas Bergquist, Per Hall JNCI Cancer Spectrum ...
JNCI Cancer Spectrum

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast.

Gabrielson M, Chiesa F, Behmer C, Rönnow K, Czene K, Hall P. Breast Cancer Res Treat. 2018 Aug;170(3):487-497. doi: 10.1007/s10549-018-4768-0. Epub ...
Breast Cancer Res Treat

Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data.

Taylor C, McGale P, Brønnum D, Correa C, Cutter D, Duane FK, Gigante B, Jensen MB, Lorenzen E, Rahimi K, Wang Z, Darby SC, Hall P, Ewertz M. J Cli...
J Clin Oncol

Identification of nine new susceptibility loci for endometrial cancer.

O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Bur...
Nat Commun

Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.

Borgquist S, Rosendahl AH, Czene K, Bhoo-Pathy N, Dorkhan M, Hall P, Brand JS. Breast Cancer Res. 2018 Aug 9;20(1):93. doi: 10.1186/s13058-018-102...
Breast Cancer Res

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, Zeng C, Feng H, Guse...
Nat Genet

A comprehensive tool for measuring mammographic density changes over time.

Eriksson M, Li J, Leifland K, Czene K, Hall P Breast Cancer Res Treat. 2018 Jun;169(2):371-379. doi: 10.1007/s10549-018-4690-5. Epub 2018 Feb 1. &...
Breast Cancer Res Treat

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meind...
Hum Mutat.

Common genetic variation and novel loci associated with volumetric mammographic density.

Brand JS, Humphreys K, Li J, Karlsson R, Hall P, Czene K. Breast Cancer Res. 2018 Apr 17;20(1):30. doi: 10.1186/s13058-018-0954-6.  ...
Breast Cancer Res

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, Dennis J, Wilcox AN, Hopper JL, Southey MC, Keeman R, Fasching PA,...
Int J Epidemiol

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.

Byström S, Eklund M, Hong MG, Fredolini C, Eriksson M, Czene K, Hall P, Schwenk JM, Gabrielson M. Breast Cancer Res. 2018 Feb 14;20(1):14. doi: 10.1...
Breast Cancer Res

Inherited factors contribute to an inverse association between preeclampsia and breast cancer.

Yang H, He W, Eriksson M, Li J, Holowko N, Chiesa F, Hall P, Czene K. Breast Cancer Res. 2018 Jan 23;20(1):6. doi: 10.1186/s13058-017-0930-6. &nbs...
Breast Cancer Res


A clinical model for identifying the short-term risk of breast cancer.

Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P. Breast Cancer Res. 2017 Mar 14;19(1):29. doi: 10.1186/s13058-017-0820-y....


A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.

Rudolph A, Fasching PA, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, Czene K, et al.  Breast Cancer Res. 2015 Aug 16;17(1):110. doi:...

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Seibold P, Schmezer P, Behrens S, Michailidou K, Bolla MK, Wang Q, Flesch-Janys D, et al.  BMC Cancer. 2015 Dec 16;15(1):978. doi: 10.1186/s12885-01...

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Schmidt

MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, et al. J Clin Oncol. 2016 Jun 6. pii: JCO665844. [Epub ahead...

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues. 

Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Rönnow K, Czene K, Östman A, et al.  Breast Cancer Res Treat. 2016 Jul;158(2):253-61. doi: ...

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, et al.  Hum Mol Genet. 2016 Jul 11. pii: ddw223. [Epub ahead of print...

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity.

Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, Hall P, Czene K. Cancer Res. 2017 Jul 1;77(13):3708-3717. doi: 10.1158/0008-5472.CAN-16...

Association analysis identifies 65 new breast cancer risk loci.

Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, et al. Nature. 2017 Nov 2;551(7678):92-94. doi: 10.1038/...